In 1947，Started business in a family workshop less than 50 m² in Japan.

In 1965，Started to produce critical pressure vessels in Japan.

In 1990，Set up Morimatus’ 1st overseas facility in Shanghai, Pudong China.

In 2002，1st time exported PED Equipment to Europe.

In 2004，Introduced advanced ERP management system.

In 2005，1st time exported Process Skids to Europe.

In 2011，Acquired Pharmadule, Pharmadule Morimatsu AB was founded and its US subsidiary was founded in New Jersey same year.

In 2013，1st overseas one-stop solution project (including on-site –installation commissioning) was completed.

In 2016，Introduced MES system to transform into an industrial 4.0 manufacturing facility.

In 2017，Morimatsu India was founded.

In 2021，Successfully listed in HK stock market.
Morimatsu Italy was founded；Malaysia joint venture was set up.

In 2022
• Morimatsu (Suzhou)LifeSciences Co., Ltd. was established.
• Shanghai Morimatsu Biotechnology Co., Ltd. was established.
• Started Construction of Changshu plant.
• Morimatsu's single-use system plant was put into operation.
• Exported one of the world's largest bioreactor projects to Europe.

In 2023
• Morimatsu (Singapore) was established.
• Morimatsu Changshu production base was put into trail operation.

In 2024
• Morimatsu (Suzhou) factory officially opened.
• Launched laboratory one-stop solution.
• Delivered over 15,000 square meters of modular plant (about 250 Pharmadule modules) for new ADC facility in Singapore.
• Exported 2 sets of single 20,000L bioreactors for cell culture meat production in USA.